Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Rejuvenation Res ; 24(2): 139-150, 2021 Apr.
Article in English | MEDLINE | ID: mdl-32567490

ABSTRACT

Osteoporosis is a silent disease caused by low bone mineral density and is complicated by fractures. This study was designed to examine the differentiation of uterine stem cell-derived osteoprogenitor cells (UOPCs) both in vitro and in vivo, assessing their effectiveness in treating osteoporosis. CD271+/CD45- UOPCs were isolated from the endometrial tissue of inbred Balb/c mice through magnetic activated cell sorting. Stem cell differentiation assays were used for CD271+/CD45- UOPCs in vitro. In vivo, the UOPCs were implanted into mouse osteoporosis models through tail-vein injection for 8 weeks. Osteogenic differentiation was examined by X-rays and computed tomography (CT) scans. Enhanced green fluorescent protein (EGFP)-labeled UOPCs, obtained from C57BL/6-Tg (ACTb-EGFP) 1Osb/J mice, were used to assess cell survival in the osteoporosis model. The levels of osteogenic markers were assessed by enzyme-linked immunosorbent assay. In vitro, UOPCs were able to form into typical spheres and various differentiations. In vivo, implantation of UOPCs into osteoporosis model significantly increased bone mineral densities and bone microstructure parameters. The levels of a biochemical marker of bone metabolism, Semaphorin-3A, increased significantly. However, levels of receptor activator of nuclear factor kappa-B ligand decreased. Immunofluorescence staining of osteoporosis mice injected with green fluorescent protein+ UOPCs showed their survival for up to 7 days. In conclusion, stem cells with osteogenic differentiation potential can be isolated from uterine or endometrial tissue. These UOPCs can stably proliferate and differentiate in vitro or in vivo, which can inhibit bone resorption and osteoclast marker expression. In vivo, UOPCs significantly improved reduction in bone density caused by reduced estrogen levels. Such cell transplantation approach is potentially useful in the treatment of osteoporosis.


Subject(s)
Mesenchymal Stem Cells , Osteoporosis , Animals , Cell Differentiation , Mice , Mice, Inbred C57BL , Osteogenesis
2.
Hum Gene Ther ; 29(2): 98-109, 2018 02.
Article in English | MEDLINE | ID: mdl-29284296

ABSTRACT

Due to the increased safety and efficiency of virus vectors, virus vector-mediated gene therapy is now widely used for various diseases, including monogenic diseases, complex disorders, and infectious diseases. Recent gene therapy trials have shown significant therapeutic benefits, and Chinese researchers have contributed significantly to this progress. This review highlights disease applications and strategies for virus vector-mediated gene therapy in preclinical studies and clinical trials in China.


Subject(s)
Gene Transfer Techniques/trends , Genetic Therapy/trends , Genetic Vectors/therapeutic use , Viruses/genetics , China , Humans
3.
Neurosci Res ; 72(1): 94-102, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22001761

ABSTRACT

Mortalin (mtHsp70) is a mitochondrial heat shock protein critical for maintaining the functional integrity of mitochondrial proteins. Our previous study demonstrated that mortalin overexpression protected against Aß-induced neurotoxicity through a mitochondria-dependent mechanism, but the molecular details remained unclear. Recent biochemical studies implicate opening of the mitochondrial permeability transition pore (mPTP) in Aß-mediated mitochondrial dysfunction. The present study investigated the effect of mortalin overexpression on Aß-induced mPTP activation and ensuing neuronal apoptosis. Mortalin overexpression inhibited mPTP activation and protected SH-SY5Y neurons against Aß-induced apoptosis. Compared to controls, neurons overexpressing mortalin also demonstrated superior intracellular free calcium regulation, lower mitochondrial reactive oxygen species generation, and decreased Bax/Bcl-2 ratios in response to Aß treatment. Mortalin overexpression suppressed activation of the mitochondrial apoptotic cascade as demonstrated by inhibition of cytochrome c release and caspase-3 activation. Our results indicate that the cytoprotective efficacy of mortalin under Aß-induced stress is mediated, at least in part, by inhibition of mPTP opening. Demonstration of the neuroprotective action of mortalin provides additional insights into the pathogenic mechanisms of Aß toxicity and defines possible molecular targets for therapeutic intervention.


Subject(s)
Amyloid beta-Peptides/toxicity , Apoptosis/physiology , HSP70 Heat-Shock Proteins/metabolism , Mitochondrial Membrane Transport Proteins/antagonists & inhibitors , Neurons/metabolism , Neuroprotective Agents/metabolism , Caspase 3/metabolism , Cell Line, Tumor , Cell Survival , Cytochromes c/metabolism , HSP70 Heat-Shock Proteins/genetics , Humans , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Mitochondrial Permeability Transition Pore , Neurons/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism , bcl-2-Associated X Protein/metabolism
4.
Neurosci Lett ; 505(3): 286-90, 2011 Nov 21.
Article in English | MEDLINE | ID: mdl-22044877

ABSTRACT

The neurotoxicity of amyloid ß (Aß) has been implicated as a critical cause in the pathogenesis of Alzheimer's disease (AD). Among antioxidant phytochemicals derived from fruit and vegetables, lycopene has recently received considerable attention for its potent protective properties already demonstrated in several models of oxidative damage. The present study aims to investigate whether lycopene could provide protective effects against Aß-induced neurotoxicity in primary cultured rat cortical neurons. The cultured cortical neurons were pretreated with different dose of lycopene for 4h, followed by the challenge with 25 µM Aß(25-35) for 24h. The results showed that pretreatment with lycopene efficiently attenuated Aß(25-35)-induced neurotoxicity, as evidenced by the improved cell viability and the decreased apoptotic rate. In addition, lycopene inhibited the reactive oxygen species generation and mitochondrial membrane potential depolarization caused by Aß(25-35). Lycopene also restored the levels of proapoptotic Bax, antiapoptotic Bcl-2, and inhibited caspase-3 activation. These beneficial effects may contribute to the protection against Aß-induced neurotoxicity. Together, our results suggest that the natural antioxidant lycopene has potential for neuroprotection and therefore, may be a promising candidate for AD treatment.


Subject(s)
Amyloid beta-Peptides/toxicity , Antioxidants/pharmacology , Carotenoids/pharmacology , Cerebral Cortex/cytology , Neurons/drug effects , Animals , Animals, Newborn , Caspase 3/metabolism , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , In Situ Nick-End Labeling , Lycopene , Membrane Potential, Mitochondrial/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , bcl-2-Associated X Protein/metabolism
5.
Neurochem Int ; 59(8): 1095-103, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22032970

ABSTRACT

Lycopene is a potent free radicals scavenger with demonstrated protective efficacy in several experimental models of oxidative damage. Trimethyltin (TMT) is an organotin compound with neurotoxic effects on the hippocampus and other limbic structures and is used to model neurodegenerative diseases targeting these brain areas. Oxidative stress is widely accepted as a central pathogenic mechanism of TMT-mediated neurotoxicity. The present study investigated whether the plant carotene lycopene protects against TMT-induced neurotoxicity in primary cultured rat hippocampal neurons. Lycopene pretreatment improved cell viability in TMT-treated hippocampal neurons and inhibited neuronal apoptosis. Microfluorometric imaging revealed that lycopene inhibited the accumulation of mitochondria-derived reactive oxygen species (ROS) during TMT exposure. Moreover, lycopene ameliorated TMT-induced activation of the mitochondrial permeability transition pore (mPTP) and the concomitant depolarization of the mitochondrial membrane potential (ΔΨ(m)). Consequently, cytochrome c release from the mitochondria and ensuing caspase-3 activation were markedly reduced. These findings reveal that lycopene protects against TMT-induced neurotoxicity by inhibiting the mitochondrial apoptotic pathway. The anti-apoptotic effect of lycopene on hippocampal neurons highlights the therapeutic potential of plant-derived antioxidants against neurodegenerative diseases.


Subject(s)
Apoptosis/drug effects , Carotenoids/pharmacology , Hippocampus/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/drug effects , Neuroprotective Agents/pharmacology , Trimethyltin Compounds/toxicity , Animals , Apoptosis/physiology , Caspase 3/metabolism , Cells, Cultured , Cytochromes c/drug effects , Cytochromes c/metabolism , Hippocampus/cytology , Hippocampus/drug effects , Lycopene , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mitochondrial Membrane Transport Proteins/drug effects , Mitochondrial Membrane Transport Proteins/physiology , Mitochondrial Permeability Transition Pore , Neurons/metabolism , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reactive Oxygen Species/pharmacology
6.
Brain Res ; 1368: 336-45, 2011 Jan 12.
Article in English | MEDLINE | ID: mdl-20974113

ABSTRACT

Amyloid-beta peptide (Aß) is shown to be toxic to the mitochondria and implicates this organelle in the pathogenesis of Alzheimer's disease. Previous studies suggest that targeting mitochondria for protection may be a useful strategy to reduce Aß-induced neurotoxicity. Mortalin is the mitochondrial located member of the heat shock protein 70 family, which serves as a major mitochondrial molecular chaperone and plays a key role in mitochondrial import of proteins. Several studies have demonstrated the protective potential of Hsp75 overexpression against apoptosis induced by various forms of stresses. To investigate whether mortalin overexpression could provide protective effects on Aß toxicity, SH-SY5Y cells were used to transfect human mortalin gene and then treated with Aß(1-42) for 24h. It is found that overexpression of mortalin efficiently attenuated Aß(1-42)-induced cell viability damage and apoptosis. Additionally, inhibition of mortalin expression by mortalin-specific siRNA oligonucleotides sensitized SH-SY5Y cells to Aß(1-42)-induced neurotoxicity. Furthermore, mortalin overexpression significantly inhibited the Aß(1-42)-induced depolarization of mitochondrial membrane potential, reversed the Aß(1-42)-induced reduction in cytochrome c oxidase activity and ATP generation, and suppressed the Aß(1-42)-induced reactive oxygen species accumulation and lipid peroxidation. Together, our results suggest that mortalin can afford protection against Aß(1-42)-induced neurotoxicity in SH-SY5Y cells. These beneficial effects of mortalin overexpression may be attributable to its roles in maintaining mitochondrial function and reducing oxidative stress.


Subject(s)
Amyloid beta-Peptides/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Neurons/metabolism , Neurotoxicity Syndromes/metabolism , Peptide Fragments/pharmacology , Apoptosis/drug effects , Apoptosis/genetics , Cell Line , Electron Transport Complex IV/drug effects , Electron Transport Complex IV/genetics , Electron Transport Complex IV/metabolism , HSP70 Heat-Shock Proteins/genetics , Humans , Lipid Peroxidation/drug effects , Lipid Peroxidation/genetics , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/genetics , Neurons/drug effects , Oligonucleotides , RNA, Small Interfering , Reactive Oxygen Species/metabolism , Transfection
7.
Article in Chinese | MEDLINE | ID: mdl-21241601

ABSTRACT

OBJECTIVE: To investigate the effects of microwave irradiation on the expression and regulation of heat shock proteins (HSPs) in primary cultured rat hippocampal neurons. METHODS: Neurons were exposed to 90 mW/cm(2) microwave irradiation for 10 minutes. Western blot was used to determine the expression of HSP27, HSP70, HSP90 and heat shock factor 1 (HSF1) at 0, 3, 6, 12 and 24 hour respectively. Real-time RT-PCR was used to determine the mRNA expression of HSF1. DNA-binding activity of HSF1 was measured by electrophoretic mobility shift assay (EMSA). RESULTS: The protein expression of HSP27 was significantly increased by 22%, 36%, 18% at 3, 6, 12 h, respectively (P < 0.05). The protein expression of HSP70 was significantly increased by 23%, 32%, 26% at 3, 6, 12 h, respectively (P < 0.05, P < 0.01). The protein expression of HSP90 was significantly increased by 27%, 33% at 6, 12 h, respectively (P < 0.05, P < 0.01). The DNA-binding activity of HSF1 was stimulated, however, no significant change of the expression of HSF1 was observed on both the mRNA and protein levels. CONCLUSION: The transcriptional activity of HSF1 is activated by microwave irradiation, which promotes the expression of HSPs. Heat shock response which contributes to establish a cytoprotective state is induced by microwave irradiation in primary cultured rat hippocampal neurons.


Subject(s)
Heat-Shock Proteins/metabolism , Hippocampus/metabolism , Hippocampus/radiation effects , Microwaves/adverse effects , Animals , Cells, Cultured , Neurons/metabolism , Rats
8.
Article in Chinese | MEDLINE | ID: mdl-15355705

ABSTRACT

OBJECTIVE: To investigate the effect of low intensity and very high frequency (VHF) electromagnetic radiation (170 MHz) on nervous system function and serum enzymes and immune function in human subjects with occupational exposure to VHF. METHODS: To measure the intensity of VHF and other environmental factors on the spot, to hold the questionnaire about chief complaints, to examine the rheoencephalography and the neurobehavior function, to analyze ALT, AST, ALP and LDH, and IgA, IgM and IgG in experimental group and control group. RESULTS: The intensity of VHF (direction of antenna: 0 degrees, 10 m and 135 degrees, 20 m) was higher than that of national standard on-the-spot. The incidences of symptoms such as headache, insomnia and amnesia etc. was significantly higher in experimental group (P < 0.01). Rheoencephalography indicated that the raising time of both left [(0.155 3 +/- 0.057 9) s] and right [(0.154 1 +/- 0.059 2) s] in the experimental group after exposure were significantly longer than before exposure [(0.104 4 +/- 0.030 2) s, (0.103 2 +/- 0.030 4) s respectively] or in the control [(0.118 5 +/- 0.056 8) s, (0.117 7 +/- 0.057 5) s respectively, (P < 0.01)]. Neurobehavior function test showed that digital symbol, digital span and pursuit aiming test were decreased after exposure in the experimental group (P < 0.01). Serum enzyme analysis showed that AST, ALP and LDH were significantly increased after exposure in the experimental group (P < 0.01). No marked change was found in IgA level, while the levels of IgM and IgG after exposure in the experimental group especially the latter were significantly increased (P < 0.01). CONCLUSIONS: Low-intensity VHF radiation can decrease the nervous system function in occupationally exposed personnel and induce increase in some kinds of enzymes and immunoglobulins.


Subject(s)
Electromagnetic Fields/adverse effects , Higher Nervous Activity/drug effects , Occupational Exposure , Radio Waves/adverse effects , Adolescent , Adult , Electroencephalography/radiation effects , Humans , Immunoglobulin G/blood , Immunoglobulin G/radiation effects , Immunoglobulin M/blood , Immunoglobulin M/radiation effects , Male , Radiation Dosage , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/radiation effects
SELECTION OF CITATIONS
SEARCH DETAIL
...